EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Peptide-functionalized nanomaterials for controlled drug delivery and regenerative therapies in retinal diseases

Razieh Dashti iD, Fariba Safaei, Golfam Sadeghian, Seyyed Abed Hosseini, Milad Salimibani iD

Journal of Biomaterials Applications · 2025

DOI: 10.1177/08853282251395196 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Biomaterials Applications, 2025. Verfasst von Razieh Dashti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nanotechnology, Graduate University of Advanced Technology, Kerman, Iran. Hauptthemen laut MEDLINE: Peptides, Retinal Diseases, Drug Delivery Systems, Nanostructures. Die Arbeit nennt 261 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Degenerative retinal diseases, such as diabetic retinopathy, age-related macular degeneration (AMD), and retinitis pigmentosa, cause irreversible vision loss by destroying vital retinal cells and represent major global health concerns. Traditional therapies have limited success in fully restoring vision due to the complex retinal structure and blood-retinal barriers (BRBs), though they may help alleviate symptoms or slow disease progression in some cases. Nanochemistry and peptide-based systems represent breakthrough approaches by leveraging nanoscale precision and biological specificity. This review examines the chemical design and synthesis of nanoparticles (NPs), nanoscaffolds, and peptide conjugates used in retinal neural regeneration. It also explores their biomedical applications, especially in targeted drug delivery, tissue engineering, and cellular repair. Biodegradable polymeric NPs, liposomes, and hybrid nanostructures are designed to cross barriers, release drugs in a controlled manner, and enhance biocompatibility. PEGylation improves stability and reduces immune responses in the ocular environment, while peptide functionalization enables specific cellular targeting and minimizes inflammatory reactions. Peptide-functionalized platforms, such as RGD-modified NPs and self-assembling hydrogels, provide receptor-mediated targeting and extracellular matrix (ECM) mimicry to support retinal regeneration for improved stem cell differentiation and neuroprotection. We discuss drug/gene delivery mechanisms, cellular interactions, and immune modulation, as well as neuroprotection, stem cell therapy, and diagnostic applications. Preclinical studies have demonstrated promising efficacy in animal models; however, concerns regarding scalability, long-term safety, and non-invasive delivery persist. Next-generation technologies, such as stimuli-responsive NPs, computationally designed peptides, and patient-specific delivery systems, are on the horizon to address unmet clinical needs. By marrying nanochemistry’s precision with peptides’ bioactivity, these technologies have the potential to transform retinal disease treatment, enabling the restoration of vision and an improvement in quality of life for millions of people worldwide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidesRetinal DiseasesDrug Delivery SystemsNanostructuresHumansAnimalsTissue EngineeringRetinaDelayed-Action PreparationsNanoparticlesRegenerative Medicine

Stichwörter der Autor:innen

drug delivery systemsnanochemistry in ophthalmologypeptide-functionalized nanoparticlesretinal regenerationself-assembling peptide hydrogels

Substanzen

PeptidesDelayed-Action Preparations

Autor:innen und Institutionen

  • Department of Nanotechnology, Graduate University of Advanced Technology, Kerman, Iran.
  • Department of Chemical Engineering, Isfahan University of Technology, Isfahan, Iran.
  • Department of Mechanical Engineering, Isfahan University of Technology, Isfahan, Iran.
  • Department of Electrical Engineering, Ma.C., Islamic Azad University, Mashhad, Iran.
  • Department of Optics and Photonics, Wroclaw University of Science and Technology, Wroclaw, Poland.

ORCID-Profile: Razieh Dashti, Milad Salimibani

Zitieren

APA

Dashti, R., Safaei, F., Sadeghian, G., Hosseini, S. A., & Salimibani, M. (2025). Peptide-functionalized nanomaterials for controlled drug delivery and regenerative therapies in retinal diseases. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282251395196

Vancouver

Dashti R, Safaei F, Sadeghian G, Hosseini SA, Salimibani M. Peptide-functionalized nanomaterials for controlled drug delivery and regenerative therapies in retinal diseases. Journal of Biomaterials Applications. 2025. doi:10.1177/08853282251395196

BibTeX
@article{Dashti2025,
  author = {Dashti, Razieh and Safaei, Fariba and Sadeghian, Golfam and Hosseini, Seyyed Abed and Salimibani, Milad},
  title = {Peptide-functionalized nanomaterials for controlled drug delivery and regenerative therapies in retinal diseases},
  journal = {Journal of Biomaterials Applications},
  year = {2025},
  doi = {10.1177/08853282251395196}
}
Kostenlos starten →